Squeeze Report — September 9, 2026
The tape is crowded with high-short-interest biotechs and broken balance sheets, but the real signal is divergence: NVAX and SRPT are already squeezing while shorts quietly cover, leaving GRPN and XXI as the most fragile float squeezes. The catalyst calendar is thin until late September, so positioning—not news—is driving these names.
Today's top short-squeeze candidates
- #1SLDBSolid Biosciences Inc. Common80
21% of float sold short · 19.6 days to cover · +16% over 20 days · options pricing in the 94th percentile (crowded)
SI 21%DTC 19.6$9.93+16% 20dHealthcare - #2CHPTChargePoint Holdings, Inc.80
25% of float sold short · 15.6 days to cover · +53% over 20 days
SI 25%DTC 15.6$9.37+53% 20dConsumer Cyclical - #3XXITwenty One Capital, Inc.79
A 58.8% float short on a tiny float, but shorts are covering and 346M total shares dilute the squeeze math.
SI 59%DTC 4.6$5.86+28% 20dFinancial Services - #4TGTXTG Therapeutics, Inc. Common S79
22% of float sold short · 12.6 days to cover · +13% over 20 days
SI 22%DTC 12.6$55.74+13% 20dHealthcare - #5GRRRGorilla Technology Group Inc.79
40% of float sold short · 5.2 days to cover · +8% over 20 days
SI 40%DTC 5.2$14.58+8% 20dTechnology - #6VERAVera Therapeutics, Inc. Class78
29% of float sold short · 7.0 days to cover · +12% over 20 days
SI 29%DTC 7.0$35.28+12% 20dHealthcare - #7CELCCelcuity Inc. Common Stock78
35% of float sold short · 13.2 days to cover · +2% over 20 days
SI 35%DTC 13.2$93.02+2% 20dHealthcare - #8CNXCConcentrix Corporation Common78
23% of float sold short · 10.6 days to cover · +11% over 20 days
SI 23%DTC 10.6$28.27+11% 20dTechnology - #9CRKComstock Resources, Inc.78
31% of float sold short · 13.4 days to cover · +6% over 20 days
SI 31%DTC 13.4$15.16+6% 20dEnergy - #10AMLXAmylyx Pharmaceuticals, Inc. C78
16% of float sold short · 7.1 days to cover · +49% over 20 days
SI 16%DTC 7.1$33.88+49% 20dHealthcare - #11SRPTSarepta Therapeutics, Inc. Com77
A 28.6% float short with two insider buys, but ELEVIDYS's boxed warning and failed confirmatory trial make this fragile.
SI 29%DTC 9.1$20.94+22% 20dHealthcare - #12PHATPhathom Pharmaceuticals, Inc.77
18% of float sold short · 6.9 days to cover · +10% over 20 days
SI 18%DTC 6.9$9.43+10% 20dHealthcare - #13VIRVir Biotechnology, Inc. Common76
15% of float sold short · 13.6 days to cover · +26% over 20 days
SI 15%DTC 13.6$11.18+26% 20dHealthcare - #14PRGOPERRIGO COMPANY PLC76
16% of float sold short · 6.9 days to cover · +15% over 20 days
SI 16%DTC 6.9$14.58+15% 20dHealthcare - #15PEGAPegasystems Inc. Common Stock76
13% of float sold short · 7.4 days to cover · +8% over 20 days
SI 13%DTC 7.4$35.80+8% 20dTechnology
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →